{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:09Z","timestamp":1790845509940,"version":"4.1.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1853","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:28:43Z","timestamp":1413329323000},"page":"2265-2272","source":"Crossref","is-referenced-by-count":55,"title":["Remedial Hydration Reduces the Incidence of Contrast-induced Nephropathy and Short-term Adverse Events in Patients with ST-segment Elevation Myocardial Infarction: A Single-center, Randomized Trial"],"prefix":"10.2169","volume":"53","author":[{"given":"Yu","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yian","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 21: 74-85, 2008.","DOI":"10.1111\/j.1540-8183.2007.00318.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 51: 1419-1428, 2008.","DOI":"10.1016\/j.jacc.2007.12.035"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341: 1413-1419, 1999.","DOI":"10.1056\/NEJM199911043411901"},{"key":"4","unstructured":"4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intra-venous thrombolytic therapy for acute myocardial infarction: a quan-titative review of 23 randomised trials. Lancet 361: 13-20, 2003."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44: 1780-1785, 2004.","DOI":"10.1016\/j.jacc.2004.07.043"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol 136: 859-861, 1981.","DOI":"10.2214\/ajr.136.5.859"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105: 624-628, 2010.","DOI":"10.1016\/j.amjcard.2009.10.044"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150: 170-177, 2009.","DOI":"10.7326\/0003-4819-150-3-200902030-00006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98: 59-77, 2006.","DOI":"10.1016\/j.amjcard.2006.01.024"},{"key":"10","unstructured":"10. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Dietin Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999."},{"key":"11","unstructured":"11. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 405: 5-37, 1968."},{"key":"12","unstructured":"12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase clinical findings through hospital discharge. Circulation 76: 142-154, 1987."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Truong QA, Cannon CP, Zakai NA, et al. Thrombolysis in Myo-cardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. Am Heart J 157: 673-679, 2009.","DOI":"10.1016\/j.ahj.2008.12.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40: 298-303, 2002.","DOI":"10.1016\/S0735-1097(02)01958-7"},{"key":"15","unstructured":"15. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44: 1393-1399, 2004."},{"key":"16","unstructured":"16. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29: 2909-2945, 2008."},{"key":"17","unstructured":"17. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarc-tion and renal dysfunction: a high-risk combination. Ann Intern Med 137: 563-570, 2002."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52: 599-604, 2008.","DOI":"10.1016\/j.jacc.2008.05.026"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93: C29-C34, 2003.","DOI":"10.1159\/000066641"},{"key":"20","unstructured":"20. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimensin 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329-336, 2002."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006.","DOI":"10.1056\/NEJMcp050801"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67: 706-713, 2005.","DOI":"10.1111\/j.1523-1755.2005.67131.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McCullough PA, Adam A, Becker CR, et al; CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98: 5K-13K, 2006.","DOI":"10.1016\/j.amjcard.2006.01.019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004.","DOI":"10.1056\/NEJMoa041365"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamaguchi J, Kasanuki H, Ishii Y, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 93: 1526-1528, 2004.","DOI":"10.1016\/j.amjcard.2004.02.065"},{"key":"26","unstructured":"26. Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. J Am Coll Cardiol JACC Cardiovasc Interv 5: 90-97, 2012."},{"key":"27","unstructured":"27. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113: 1799-1806, 2006."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tziakas D, Chalikias G, Stakos D, et al. Development of an easily applicable risk score model for contrast-induced Nephropathy prediction after percutaneous coronary intervention A novel approach tailored to current practice. Int J Cardiol 163: 46-55, 2013.","DOI":"10.1016\/j.ijcard.2011.05.079"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. McCullough PA, Manley HJ. Prediction and prevention of contrast nephropathy. J Interv Cardiol 14: 547-558, 2001.","DOI":"10.1111\/j.1540-8183.2001.tb00371.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short-and long-term clinical outcomes in patients with ST-elevation myocardial linfarction. Circ Cardiovasc Interv 3: 491-498, 2010.","DOI":"10.1161\/CIRCINTERVENTIONS.110.955310"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.1853\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:51:26Z","timestamp":1621446686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.1853\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1853","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}